Robert D. Hardie

Insider Reports History

Location
Charlottesville, VA
Signature
/s/ Katherine Denby, Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Robert D. Hardie:

Company Role Class Num Shares Value Price $ Report Date Ownership
Acumen Pharmaceuticals, Inc. 10%+ Owner Common Stock 657,985 $2,283,603 $3.47 06 Jul 2021 Indirect
Acumen Pharmaceuticals, Inc. 10%+ Owner Series A-1 Preferred Stock 0 06 Jul 2021 Indirect
Acumen Pharmaceuticals, Inc. 10%+ Owner Series B Preferred Stock 0 06 Jul 2021 Indirect

Insider Reports Filed by Robert D. Hardie

Symbol Company Period Transactions Value $ Form Type Role Filing Time
ABOS Acumen Pharmaceuticals, Inc. 06 Jul 2021 6 +$5,000,000 4 10%+ Owner 08 Jul 2021, 18:15
ABOS Acumen Pharmaceuticals, Inc. 06 Jul 2021 5 +$12,000,000 4 10%+ Owner 08 Jul 2021, 18:14
ABOS Acumen Pharmaceuticals, Inc. 30 Jun 2021 0 $0 3 10%+ Owner 30 Jun 2021, 19:12